A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurised cow's milk in Slovakia  by Liptakova, A. et al.
7. Nataro JP, Seriwatano J, Fasano A et al. Identiﬁcation and
cloning of a novel plasmid-encoded enterotoxin of en-
teroinvasive Escherichia coli and Shigella strains. Infect Im-
mun 1995; 63: 4721–4728.
8. Noriega FR, Liao FM, Formal SB, Fassano A, Levine MM.
Prevalence of Shigella enterotoxin among Shigella clinical
isolates of diverse serotypes. J Infect Dis 1995; 172: 1408–
1410.
9. Henderson I, Czeczulin J, Eslava C, Noriega F, Nataro JP.
Characterization of Pic, a secreted protease of Shigella
ﬂexneri and enteroaggregative Escherichia coli. Infect Immun
1999; 67: 5587–5596.
10. Vargas M, Gascon J, Jimenez De Anta MT, Vila J. Preval-
ence of Shigella enterotoxins 1 and 2 among Shigella strains
isolated from patients with traveller’s diarrhoea. J Clin
Microbiol 1999; 27: 3608–3611.
11. World Health Organization. Manual for laboratory investi-
gations of acute enteric infections. Document
WHO ⁄CDD ⁄ 83.3. Geneva: WHO, 1983.
12. Ruiz J, Navia MM, Gasco´n J, Vila J. Prevalence of the sat
gene among clinical isolates of Shigella spp. causing trav-
ellers diarrhea: geographical and speciﬁc differences.
J Clin Microbiol 2002; 40: 1565–1566.
RESEARCH NOTE
A family outbreak of haemolytic uraemic
syndrome and haemorrhagic colitis caused
by verocytotoxigenic Escherichia coli O157
from unpasteurised cow’s milk in Slovakia
A. Liptakova1, L. Siegfried1, J. Rosocha2,
L. Podracka3, E. Bogyiova1 and D. Kotulova4
1Institute of Medical Microbiology, 2Associated
Tissue Bank, 3Hospital for Sick Children, Med-
ical Faculty, P. J. Safarik University, Kosˇice and
4Institute of Microbiology, Medical Faculty,
Comenius University, Bratislava, Slovakia
ABSTRACT
This report describes a family outbreak of vero-
cytotoxigenic Escherichia coli O157 (VTEC) infec-
tion, involving nine persons from one extended
family, which occurred in eastern Slovakia. Three
children suffered from haemolytic uraemic syn-
drome, two children had bloody diarrhoea, and
four adults were asymptomatic carriers. Fourteen
sorbitol-non-fermenting E. coli O157 isolates har-
bouring the vtx2, eae and ehxA genes were
obtained. Verocytotoxin 2 activity was demon-
strated in all 14 isolates. After epidemiological
surveillance, the source of infection was identiﬁed
as unpasteurised cow’s milk.
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The association between Escherichia coliO157 infec-
tion, haemorrhagic colitis (HC) (with diarrhoea,
severe abdominal pain and blood in the stools) and
haemolytic uraemic syndrome (HUS) was estab-
lished in the early 1980s [1]. Verocytotoxigenic
E. coli (VTEC) strains have been recognised as the
cause of both outbreaks and sporadic cases of
diarrhoea and HUS, involving thousands of cases
and numerous deaths [2,3]. Transmission of VTEC
O157 to humans is associated mostly with con-
sumption of contaminated food, unpasteurised
milk and ready-to-eat products [4]. Cattle comprise
themajor reservoir, but other farm animals can also
be carriers of E. coliO157 [5–8]. Several milk-borne
outbreaks of VTEC have been reported [9,10].
The present study describes a family outbreak
of VTEC O157, causing HUS and HC in paediatric
patients. The family consisted of 14 members (nine
adults and ﬁve children) living in a village in
eastern Slovakia. The household also included
goats and cattle. Diagnosis of HUS and HC was
based on the occurrence of acute haemolytic
anaemia with red cell fragmentation, acute renal
failure, thrombocytopenia below 130 ⁄mL, and the
presence of blood in the stools. Five children
(a boy aged 15 months, his sister aged 33 months,
and three cousins: a boy aged 5 years, a girl aged
31 months and a girl aged 7 years) were admitted
to hospital, with the two children aged 15 and
33 months suffering from acute renal failure. The
boy aged 15 months experienced a 4-day period of
mild watery diarrhoea which began on 8 Novem-
ber and continued as bloody diarrhoea from 11
November. On 14 November, the patient was
hospitalised for HUS. His sister developed bloody
diarrhoea on 14 November and was hospitalised
for HUS on 15 November. Both children required
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peritoneal dialysis. Blood samples taken from the
patients showed typical schistocytes and thromb-
ocytopenia with anaemia, and leukocytosis was
also found in the girl. The cousin aged 31 months
also developed HUS, but required only sympto-
matic treatment without dialysis. The older chil-
dren suffered from bloody diarrhoea.
During the outbreak, 69 samples were collected
from different sources: human stools (54), goat
milk (one), goat stool (one), food sample—an
apple extract (one), unpasteurised cow’s milk
(seven) and bovine faecal samples (ﬁve). Samples
were examined for the presence of VTEC O157.
Specimens were cultivated in Luria Bertani broth
and trypticase-soya broth, and were plated on
blood agar, MacConkey agar and sorbitol Mac-
Conkey agar containing ceﬁxime 0.05 mg ⁄L and
potassium tellurite 2.5 mg ⁄L (CT-SMAC). Puta-
tive VTEC O157 were identiﬁed as sorbitol-non-
fermenting colonies after incubation at 37C for
18 h. Between ﬁve and ten colonies were tested for
agglutination with an E. coli O157 Test Kit (Oxoid,
Basingstoke, UK), used according to the manufac-
turer’s instructions. Immunomagnetic separation
with Dynabeads anti-E. coli O157 (Dynal, Oslo,
Norway) was used for isolation of E. coli O157.
Sorbitol-non-fermenting colonies were picked and
their identity was conﬁrmed biochemically.
Physicians were asked to submit serial stool
samples collected from positive individuals at
2–4-day intervals. All E. coli O157 isolates were
tested for the presence of verocytotoxins 1 and 2
(Vtx1 and Vtx2) with a VTEC reverse passive
latex agglutination kit (Oxoid). The enterohaemo-
lytic phenotype (EhxA) was detected on entero-
haemolysin agar. Genes encoding Vtx1 and Vtx2
(vtx1 and vtx2), enterohaemolysin (ehxA) and
intimin (eae) were detected by multiplex PCR
[11]. Epidemiological information was obtained
by semi-structured interviews undertaken by
Epidemiology Unit staff with all family members
and contacts.
Screening of stools from the children yielded
E. coli O157, as did stools from the four parents of
the infected children, although no clinical signs
were shown by the adults. The stool specimens
were obtained at regular intervals, with length of
shedding of VTEC as shown in Fig. 1.
In order to trace the source of infection, sam-
ples of food, goat milk, goat faeces, bovine milk
and bovine faeces were analysed on 25 Novem-
ber. In total, 22 sorbitol-non-fermenting E. coli
O157 isolates were obtained from the nine family
members, four E. coli O157 were isolated from
four bovine faecal samples, and one was isolated
from a sample of cow’s milk (Table 1). All family
members who were positive for VTEC O157 had
consumed cream prepared from unpasteurised
cow’s milk.
E. coli O157:H7 is the predominant VTEC
serotype isolated in the USA, Canada, Japan and
Europe [12,13]. VTEC strains belonging to other
serotypes (non-O157 VTEC) have also been
responsible for outbreaks and sporadic cases of
human disease in continental Europe [14–17]. The
present study reports the ﬁrst cases of HUS and
HC in Slovakia caused by VTEC O157. Such
microorganisms can be detected easily by toxin-
independent detection protocols, such as the
immunomagnetic separation technique. How-
ever, the stool samples from the affected children
were bloody, and E. coli O157 strains were
isolated after overnight incubation on CT-SMAC
without immunomagnetic separation. In contrast,
the stools from the adults were non-haemor-


































Fig. 1. Recovery of Escherichia coli O157 in stool samples
from infected family members. The duration of shedding
was estimated as the interval from the ﬁrst O157-positive
culture (followed by three negative stool cultures collected
at 2–4-day intervals). HUS1, male aged 15 months with
haemolytic uraemic syndrome (HUS); HUS2, female aged
33 months with HUS; HUS3, female aged 31 months with
HUS; HC1, male aged 5 years with haemorrhagic colitis
(HC); HC2, female aged 7 years with HC; AC1, asympto-
matic female (mother of HC1 and HC2); AC2, asympto-
matic male (father of HUS3); AC3, asymptomatic male
(father of HUS1 and HUS2); AC4, asymptomatic female
(mother of HUS3).
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The outbreak involved only the extended
family members living in the same surroundings.
It is not surprising that the serious clinical
complications developed among the youngest
children, while even the VTEC-positive adults
were asymptomatic. This age-related incidence
can be explained in terms of receptor distribu-
tion, because verocytotoxin-binding sites are
found in the renal glomeruli of infants, but not
of adults [18].
The presence of E. coli positive for Vtx2 only
is in accordance with other ﬁndings throughout
Europe [16]. Genotypic analysis of a VTEC
isolate may be of considerable microbiological
and clinical signiﬁcance [7]. Multiplex PCR was
used for detection of the vtx1, vtx2, eae and ehxA
genes. All the E. coli isolates were indistinguish-
able in terms of serotype (O157), virulence
properties (Vtx1–, Vtx2+, EhxA+) and genes
encoding virulence factors (vtx1–, vtx2+, eae+,
ehxA+), indicating that the same strain caused
the infections.
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Table 1. Characteristics of

















vtx1 vtx2 eae ehxA
9 22 22 – 22 22 22 22 0 22 22 22
5 12 12 – 0 0 0 0 0 0 0 0
– 5 – 5 5 5 5 5 0 5 5 5
Vtx2, verocytotoxin 2; EhxA, enterohaemolysin phenotype; vtx1, gene encoding verocytotoxin 1; vtx2, gene
encoding verocytotoxin 2; eae, gene encoding intimin; ehxA, gene encoding enterohaemolysin.
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